
Challenges with Using ASN/EDI for Passing Lot-Based DSCSA Transaction Data
Challenges with Using ASN/EDI for Passing Lot-Based DSCSA Transaction Data. At TrackTraceRx we deal with our clients EDI/ASN integration on a daily basis.
Home » Traceability » Page 10
Challenges with Using ASN/EDI for Passing Lot-Based DSCSA Transaction Data. At TrackTraceRx we deal with our clients EDI/ASN integration on a daily basis.
Wholesale Distributor Annual Reporting Deadline. This is one of the most important deadlines in the entire pharmaceutical industry.
A secure web portal with data exchange capabilities is not enough – document storage and retrieval features need to be added to the feature mix for real value addition.
Regarding serialization, there exist a number of questions that need to be answered directly by the FDA. If companies chooses not to randomize, they run the risk of having someone in the supply chain.
Know how to Handle DSCSA Exceptions as a pharmaceutical company or as a manufacturer, a re-packager, distributor or a dispenser.
Know how to choose the appropriate ERP solution partner for your pharmaceutical company and meet the DSCSA compliance requirements with ease.
Use the Extension in Deadline for DSCSA Data Exchange Enforcement to Your Advantage. Be a leader in the pharmaceutical industry.
One of the questions we get at TrackTraceRx is, “how do I notify the FDA if i discover a counterfeit product within my supply chain?”. Get there answer here.
Understanding the Drug Supply Chain Security Act (DSCSA) is important to sustain in the pharmaceutical industry. Get all the details here.
Before trying to making sense of the FDA’s definition of the ‘interoperability’, it’s worth revisiting the DSCSA timeline for data exchange
Shaping the future of traceability and serialization since 2007